Indeed, a high CD44/CD24 ratio in breast cancer has been shown as an important breast cancer prognosis predictor [11] and also to be enriched in circulating tumor cells [12,13] and in distant metastases, such as in liver [11], bone [14], and lung [15]. This evidence concerns the gene CD44 and breast carcinoma.